(Q44208733)

30 November 2017

title

Lamotrigine monotherapy for control of neuralgia after nerve section (English)

1 reference

30 November 2017

1 reference

A Sandner-Kiesling

1

1 reference

30 November 2017

G Rumpold Seitlinger

2

1 reference

30 November 2017

C Dorn

3

1 reference

30 November 2017

H Koch

4

1 reference

30 November 2017

G Schwarz

5

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Acta Anaesthesiologica Scandinavica

30 November 2017

published in

1 reference

30 November 2017

volume

46

1 reference

30 November 2017

issue

10

1 reference

30 November 2017

page(s)

1261-1264

1 reference

A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.461014.X

Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.461014.X

Lamotrigine for central poststroke pain: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.461014.X

Anticonvulsants (antineuropathics) for neuropathic pain syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.461014.X

A systematic review of antidepressants in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.461014.X

7 January 2021

Lamotrigine in the management of neuropathic pain: a review of the literature

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.461014.X

7 January 2021

Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.461014.X

7 January 2021

Lamotrigine in spinal cord injury pain: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.461014.X

7 January 2021

Anticonvulsant hypersensitivity syndrome: incidence, prevention and management

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.461014.X

7 January 2021

A stable prostacyclin analog enhances ectopic activity in rat sensory neurons following neuropathic injury

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.461014.X

7 January 2021

Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.461014.X

7 January 2021

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.461014.X

7 January 2021

Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.461014.X

7 January 2021

Serious dermatologic reactions in children.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.461014.X

7 January 2021

Lamotrigine in the treatment of chronic refractory neuropathic pain

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2002.461014.X

7 January 2021

10.1034/J.1399-6576.2002.461014.X

Identifiers

DOI

1 reference

30 November 2017

1 reference